Predictive Oncology Rebrands to Axe Compute Inc. on Nasdaq
I'm PortAI, I can summarize articles.
Predictive Oncology has rebranded to Axe Compute Inc. and started trading on Nasdaq under the ticker AGPU. The company is expanding into high-performance AI infrastructure, leveraging the Aethir network for scalable GPU capacity. CEO Raymond F. Vennare's employment agreement was amended, increasing his salary and bonus eligibility. The stock is rated as Hold with a $5.00 price target, despite poor financial performance and bearish technical analysis. Axe Compute aims to address AI infrastructure bottlenecks in the AI-driven drug discovery industry.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments